Bryant Moeller

A combinatorial model was devised to predict pulmonary hypertension using systolic pulmonary artery pressure and forced vital capacity in older adults.

Researchers sought to determine if selexipag can be associated with lower hospitalization rates through analysis of real-world hospitalization rates of patients taking either selexipag or treprostinil.

An association between ventricular function and vascular loading and outcomes was observed in patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary thromboendarterectomy.

Patients with sleep apnea who received positive airway pressure therapy did not exhibit reduced cardiovascular risk compared with patients who received usual care.

Oral combination therapy does not appear to help achieve or maintain low risk status in most treatment-naive patients with pulmonary arterial hypertension.

A robot-assisted ultrasound system was able to remotely assess cardiopulmonary features in patients with COVID-19.

Incorporating preoperative right heart measurements into the standard pulmonary hypertension risk estimation model may allow for better risk stratification following aortic valve replacement.

Patients with both type 2 diabetes and obstructive sleep apnea demonstrated macrovascular endothelial dysfunction beyond the effect of either disease alone.

Patients with obstructive sleep apnea who received positive airway pressure therapy had greater improvements in blood pressure compared with those who received upper airway stimulation.

Patients with chronic thromboembolic pulmonary hypertension had increased plasma concentrations of osteopontin, which may be involved in fibrotic remodeling.